The House Committee on Energy and Commerce
|
|
-
January 29, 2003
-
Committee Hearing
Do Not Call List Authorization.
Full Committee on Energy and Commerce
January 8, 2003
-
Committee Hearing
Examining Issues Related to Competition in the Pharmaceutical Marketplace: A Review of the FTC Report, 'Generic Drug Entry Prior to Patent Expiration'
Subcommittee on Health
October 9, 2002
-
Committee Hearing
The FTC's Franchise Rule: Twenty-Three Years After Its Promulgation
Subcommittee on Commerce, Trade, and Consumer Protection
June 25, 2002
-
Director, Office of Research Integrity, Office of Public Health and Science
Department of Health and Human Services
ORI's Failure to Publish New Policies in the Federal Register
February 5, 2001
|
|
|
Comment
On This Page
|
| |
